Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BI 885578 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
BI 885578 is a dual inhibitor of insulin like growth factor-1 receptor (IGF1R) and insulin receptor (INSR) that blocks downstream signaling and leads to growth inhibition in tumor cells (PMID: 26438154, PMID: 28729397). |
| DrugClasses | IGF-1R Inhibitor 17 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BI 885578 | BI 885578 | 0 | 0 |
| BI 885578 + Fluorouracil | BI 885578 Fluorouracil | 0 | 0 |
| BI 885578 + Irinotecan | BI 885578 Irinotecan | 0 | 0 |
| BI 885578 + Nintedanib | BI 885578 Nintedanib | 0 | 0 |